InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (7 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
7
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the full record of transactions filed by Fairman Jeff, Vice-Président de la Recherche. Insider active across 1 company, notably Vaxcyte, Inc.. Cumulatively, 19 filings have been logged. Breakdown: 0 buy · 7 sells. Total volume traded: €1.2m. History available since 7 June 2021. The latest transaction was disclosed on 26 October 2022 (Cession). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Fairman Jeff
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations19 total
10,000 shares@ US$40.0028.8% of flowCommon StockSEC:0001209191-22-054858:0
5,000 shares@ US$25.509.5% of flowCommon StockSEC:0001209191-22-053579:0
519 shares@ US$26.381.0% of flowCommon StockSEC:0001209191-22-049025:0
10,000 shares@ US$25.5018.1% of flowCommon StockSEC:0001209191-22-044659:0
4,112 shares@ US$25.500.0016% mcap16.9% of flowCommon StockSEC:0001209191-22-031619:0
888 shares@ US$25.80451.6% of flowCommon StockSEC:0001209191-22-027848:0
5,000 shares@ US$25.598.9% of flowCommon StockSEC:0001209191-22-023695:0
10,000 shares@ US$25.5017.6% of flowCommon StockSEC:0001209191-22-019027:0
6,000 shares0Common StockSEC:0001209191-22-016524:0
4,469 shares@ US$1.790.5% of flowCommon StockSEC:0001209191-22-007789:0
4,750 shares@ US$1.790.6% of flowCommon StockSEC:0001209191-21-071376:0
4,619 shares@ US$1.790.6% of flowCommon StockSEC:0001209191-21-070572:0
131 shares@ US$1.790.0% of flowCommon StockSEC:0001209191-21-069292:0
4,750 shares@ US$1.790.6% of flowCommon StockSEC:0001209191-21-061940:0
4,750 shares@ US$1.790.6% of flowCommon StockSEC:0001209191-21-058125:0
4,750 shares@ US$1.790.5% of flowCommon StockSEC:0001209191-21-053901:0
4,750 shares@ US$1.790.5% of flowCommon StockSEC:0001209191-21-048429:0
4,750 shares@ US$1.790.5% of flowCommon StockSEC:0001209191-21-044018:0
7,259 shares@ US$0.040.0% of flowCommon StockSEC:0001209191-21-039204:0
19 of 19 declarations
About Fairman Jeff
Fairman Jeff is Vice-President of Research and is linked to Vaxcyte, Inc. (XNAS) as VP, Research. He has 19 filings in total, and the sampled recent filings cover the period from 2021-06-09 to 2022-10-28, with EUR 0 of buys and EUR 1246330 of sells, and the most common transaction nature is Option exercise.
